z-logo
open-access-imgOpen Access
Quetiapine versus aripiprazole in the management of schizophrenia
Author(s) -
Saeed Shoja Shafti,
Hamid Kaviani
Publication year - 2015
Publication title -
therapeutic advances in psychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 2045-1261
pISSN - 2045-1253
DOI - 10.1177/2045125315579870
Subject(s) - aripiprazole , quetiapine , schizophrenia (object oriented programming) , medicine , psychiatry , quetiapine fumarate , psychology , atypical antipsychotic , antipsychotic
Current evidence supports the use of various second-generation antipsychotics for pharmacotherapy of schizophrenia. While in a systematic review, generally no difference in efficacy was found between atypical antipsychotics, other studies have found quetiapine less effective than aripiprazole. This article reviews the efficacy and tolerability of aripiprazole versus quetiapine in the context of recommended management strategies for schizophrenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom